The emerging treatment of the medication represents a significant advance in the handling of the condition. Distinct from existing medications, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide448009.idblogmaker.com/40768040/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment